Coherus Biosciences Inc (NASDAQ: CHRS) is -39.23% lower on its value in year-to-date trading and has touched a low of $0.66 and a high of $2.61 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CHRS stock was last observed hovering at around $0.85 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.84, the stock is -12.62% and -23.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.29 million and changing -1.46% at the moment leaves the stock -32.82% off its SMA200. CHRS registered -63.54% loss for a year compared to 6-month gain of -15.37%. The firm has a 50-day simple moving average (SMA 50) of $1.09288 and a 200-day simple moving average (SMA200) of $1.24839.
The stock witnessed a -22.35% loss in the last 1 month and extending the period to 3 months gives it a -42.95%, and is -18.58% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.12% over the week and 10.33% over the month.
Coherus Biosciences Inc (CHRS) has around 228 employees, a market worth around $97.19M and $266.96M in sales. Current P/E ratio is 4.81. Profit margin for the company is 10.68%. Distance from 52-week low is 27.00% and -67.87% from its 52-week high. The company has generated returns on investments over the last 12 months (17.40%).
The EPS is expected to shrink by -81.14% this year.
Coherus Biosciences Inc (CHRS) Top Institutional Holders
165.0 institutions hold shares in Coherus Biosciences Inc (CHRS), with institutional investors hold 58.36% of the company’s shares. The shares outstanding are 115.61M, and float is at 111.29M with Short Float at 29.25%. Institutions hold 57.56% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.75 million shares valued at $20.33 million. The investor’s holdings represent 10.2356% of the CHRS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.6 million shares valued at $18.34 million to account for 9.4035 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 10.4 million shares representing 9.0577% and valued at over $17.99 million, while TEMASEK HOLDINGS (PRIVATE) LTD holds 5.0678 of the shares totaling 5.82 million with a market value of $10.07 million.
Coherus Biosciences Inc (CHRS) Insider Activity
#####
